Baseline White Blood Cell Count Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome, but It Does Not Improve the Risk Classification of the GRACE Score

• Published in: Cardiology Vol. 124; no. 2; pp. 97 - 104
• Main Authors: Taglieri, Nevio, Bacchi Reggiani, Maria Letizia, Palmerini, Tullio, Cinti, Laura, Saia, Francesco, Guastaroba, Paolo, Marrozzini, Cinzia, Moretti, Carolina, Montefiori, Michela, Rosmini, Stefania, Alessi, Laura, Vagnarelli, Fabio, Branzi, Angelo, Rapezzi, Claudio, Marzocchi, Antonio
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.01.2013
• Subjects: Acute Coronary Syndrome - mortality; Acute coronary syndromes; Aged; Aged, 80 and over; Cardiovascular Diseases - mortality; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukocyte Count; Leukocytes; Male; Mortality; Original Research; Prognosis; Risk Assessment - methods; Risk factors; White blood cell count; Global Registry of Acute Coronary Events score; Cardiovascular mortality
• ISSN: 0008-6312; 1421-9751
• DOI: 10.1159/000346377

Objectives: To investigate the prognostic significance of baseline white blood cell count (WBCc) in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and its additive predictive value beyond the Global Registry of Acute Coronary Events (GRACE) score. Methods: We included 1,315 consecutive NSTE-ACS patients. Patients were divided in quartiles according to the WBCc (cells per 1 mm 3 ) i.e. Q1 <6,850, Q2 = 6,850–8,539, Q3 = 8,540–10,857 and Q4 ≥10,858. The study end point was 3-year cardiovascular death (CVD). Results: The median age of the study population was 76 years. Overall, 335 patients (25.5%) died with 211 of these (16%) suffering from CVD. Patients in Q4 showed a higher cumulative probability of CVD compared to patients in Q1–Q3. On multivariable analysis, patients in Q4 were at higher risk of CVD [hazard ratio (HR) = 1.47, 95% confidence interval (CI) 1.09–1.98, p = 0.011]. WBCc as a continuous variable was also independently associated with the study end point (HR = 1.043; 95% CI 1.02–1.07; p = 0.001). However, the incorporation of WBCc into the GRACE score did not improve either prediction of risk (C-index = 0.796 for GRACE score with or without WBCc) or classification of risk [relative integrated discrimination improvement = 0.0154, 95% CI) –0.029 to 0.0618; continuous net reclassification improvement = –0.0676, 95% CI –0.2149–0.0738). Conclusions: WBCc was an independent predictor of 3-year CVD in patients with NSTE-ACS. However, it did not add prognostic information beyond the GRACE score.